An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer.
about
Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.Clinicopathological variables predicting HER-2 gene status in immunohistochemistry-equivocal (2+) invasive breast cancer.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy.A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trialsSystemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?
P2860
Q30251429-5D64B49A-1915-468C-A65E-17E48E8814B4Q33995239-927C1D18-CBC2-4A79-935A-B79BFD325625Q34103963-F976F895-4526-432A-98B2-CA05DE6D1CA5Q34567451-4209E47C-16FA-452E-92A7-909A2DA929D8Q37143133-910F1030-6785-4802-93B7-BB2A5C4AA9D7Q37148642-557E2A78-F48A-42D2-A0A1-9FFCE5B8E4DDQ37704313-50D4F0CA-3FF0-436B-A0BE-423E65570F58Q38575259-32DE43D8-DD18-4D05-8D72-133D0A13EA7D
P2860
An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
An open-label safety study of ...... tive metastatic breast cancer.
@ast
An open-label safety study of ...... tive metastatic breast cancer.
@en
type
label
An open-label safety study of ...... tive metastatic breast cancer.
@ast
An open-label safety study of ...... tive metastatic breast cancer.
@en
prefLabel
An open-label safety study of ...... tive metastatic breast cancer.
@ast
An open-label safety study of ...... tive metastatic breast cancer.
@en
P2093
P2860
P1433
P1476
An open-label safety study of ...... itive metastatic breast cancer
@en
P2093
Abenaa M Brewster
Alejandra Perez
Allison M Florance
Maura K Hagan
Robert A Somer
Sandra X Franco
Simon Turner
Steven Stein
Will Williams
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0129
P577
2013-05-22T00:00:00Z